about
Objective sleep structure and cardiovascular risk factors in the general population: the HypnoLaus Study.Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patientsNovel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index.Pulse wave amplitude drops during sleep are reliable surrogate markers of changes in cortical activity.Genes for normal sleep and sleep disorders.Genetics of narcolepsy and other major sleep disorders.The loss of circadian PAR bZip transcription factors results in epilepsy.Invited review: genetic dissection of sleep.Pharmacogenomics in the treatment of narcolepsy.Genetics of sleep and sleep disorders.A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy.Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study.CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditionsGenetics of normal and pathological sleep in humans.Differential effects of sodium oxybate and baclofen on EEG, sleep, neurobehavioral performance, and memory.Homer1a is a core brain molecular correlate of sleep lossMolecular genetics and treatment of narcolepsy.Sleep Characteristics in Early Stages of Chronic Kidney Disease in the HypnoLaus Cohort.Narcolepsy and familial advanced sleep-phase syndrome: molecular genetics of sleep disorders.Functional implication of the vitamin A signaling pathway in the brain.Molecular analysis of sleep.Genetics of sleep.The genetic basis of sleep disorders.DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.Genetic aspects of normal and disturbed sleep.Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.Central and peripheral metabolic changes induced by gamma-hydroxybutyrate.Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy.Cytokine-induced sleep: Neurons respond to TNF with production of chemokines and increased expression of Homer1a in vitro.Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study.Homeostatic process and sleep spindles in patients with sleep-maintenance insomnia: effect of partial (21 h) sleep deprivation.The European Narcolepsy Network (EU-NN) database.Prevalence and determinants of periodic limb movements in the general population.Circadian distribution of rest/activity in narcoleptic and control dogs: assessment with ambulatory activity monitoring.Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.Cerebral mGluR5 availability contributes to elevated sleep need and behavioral adjustment after sleep deprivation.Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.Monozygotic twins affected with Kleine-Levin syndromeHLA-DQ allele competition in narcolepsy: where is the evidence?HLA and genetic susceptibility to sleepwalking.
P50
Q30404186-C49CF93A-4CA5-49A2-AFE1-75223E527F97Q33685660-E761A4BE-E7D8-4DAB-A7D6-B271E7BA049DQ33981739-1194773E-1097-4954-BF0B-C46623617B25Q34315465-73F0F1BF-CA75-4D36-8E03-9DF4A3AC96CBQ34474283-4FEE8913-0FCC-48AF-B75D-B52BF6479C9EQ34490745-CC2E6431-075D-4821-B0E4-3D5C5950C3B8Q34510790-07AB1C34-FE1A-457A-8B62-6826CEE076E7Q34528172-B0FD3CBA-E871-4A0C-9EEB-D8CD1C1700A4Q35040879-0900BA0C-675E-4F2A-A007-C5D69491F597Q35109485-F827FB02-18D8-4D93-AFBC-0A496A8C965FQ35204907-3CCAC818-7106-48F2-BEAB-B26388970C29Q35499099-A36AC628-E486-493C-973A-FABCE538B9D5Q35560285-8A040AB9-6FA7-4BB9-BDE6-C3D65BCE482CQ36057687-958ED27F-953F-434E-A088-6F3CFAA95220Q36097721-5C304323-E7FC-444D-A1C7-9E7B24FD1D69Q36289069-790EE19F-07F4-4566-BCD3-17BD67401642Q36497536-1C3A1155-2B08-4EDF-BF2E-1CBB1432B0C0Q36686539-DE9C106F-837E-4B83-AFC4-93B292A1259AQ36805488-D1DF83E2-9D3D-4D19-A93E-ECF79B9AD21FQ37028672-0109AD30-4B0A-48F5-9D0C-90231BE485C1Q37141114-1B5E9196-F46A-401F-8219-641D70CAE352Q37317011-C632CBD3-2704-4FEC-9C91-A8748E82433BQ37347392-2F19B4FE-4903-445F-9EEA-2E4280CE017CQ37397544-6A1D4BCB-5840-4336-BB78-2B8D2D75A39EQ37574620-90F08251-130D-4DC8-900F-9D4D02D58347Q38281468-F43AF4CD-2301-4B88-8749-3C688BB9E654Q38302187-8FEBD1FD-A3B5-49B3-8416-3C5CDBA9FD0CQ38366488-07ED9F6B-7C28-4423-A5D6-13076C950449Q38932134-F387FCB6-B5CF-4E48-B706-B379E58B1F68Q39048727-06C38860-2401-48AB-A1F6-072D8A908EC1Q39476087-A7393AD0-98A9-43C2-A347-B012F1E7D600Q40062905-EA27D29D-F624-40FF-AB23-9687828292B6Q40171632-4BB2AB4A-EFDC-4E63-A1A0-B7171B73E0E8Q40891632-15B8D3CD-445C-4456-A09A-6B26B0B7DA46Q42283162-1258BB2B-D7DA-4C34-9244-0B079F96D3E5Q42379497-0186C002-D7A6-4496-822F-22727FA12756Q42454986-059FB375-5096-422A-96A7-982946E588E2Q42554186-C5CFB511-72A4-469F-9DE3-918AF95B6CA3Q42571334-9C0AE2A7-FEA2-46FC-801E-68EB459BAE68Q42693840-44D6E5B5-9BAE-49A8-8E8C-8D31376AACDF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Mehdi Tafti
@ast
Mehdi Tafti
@en
Mehdi Tafti
@es
Mehdi Tafti
@nl
Mehdi Tafti
@sl
type
label
Mehdi Tafti
@ast
Mehdi Tafti
@en
Mehdi Tafti
@es
Mehdi Tafti
@nl
Mehdi Tafti
@sl
prefLabel
Mehdi Tafti
@ast
Mehdi Tafti
@en
Mehdi Tafti
@es
Mehdi Tafti
@nl
Mehdi Tafti
@sl
P1006
P214
P1006
P1053
A-8887-2017
P106
P21
P213
0000 0003 5066 1467
P214
P31
P3829
P496
0000-0002-6997-3914
P7859
viaf-287367873